$115.46
3M Ago | 1M Ago | Current | |
Buy | 13 | 13 | 13 |
Outperform | 11 | 12 | 12 |
Hold | 9 | 8 | 8 |
Underperform | 0 | 0 | 0 |
Sell | 1 | 1 | 1 |
The latest share price target for Neurocrine Biosciences Inc. (NBIX) is $129.59, offered by 34 analysts offering 12-month price forecasts.
Neurocrine Biosciences Inc. (NBIX) has a maximum of 0.12 upside potential, based on 34 analysts offering 12-month price forecasts.
Based on 34 analysts tracking and researching Neurocrine Biosciences Inc. (NBIX), 73.53% have a buy recommendation. Remaining 26.47% have either sell or hold recommendations.
The latest share price of Neurocrine Biosciences Inc. (NBIX) is $115.46 as of 29/09/2023.
25 of total 34 analysts offering stock ratings for Neurocrine Biosciences Inc. NBIX have recommended buy rating.